The effect of ICD programming on inappropriate and appropriate ICD therapies in ischemic and nonischemic cardiomyopathy: The MADIT-RIT trial

Journal of Cardiovascular Electrophysiology

Volumn 26, Issue 4, 2015, Pages 424-433

  Sedláček, Kamil ^a   Ruwald, Anne Christine ^b,c   Kutyifa, Valentina ^b   McNitt, Scott ^b   Thomsen, Poul Erik Bloch ^e   Klein, Helmut ^b   Stockburger, Martin ^d   Wichterle, Dan ^a   Merkely, Bela ^f   De La Concha, Joaquin Fernandez ^g   Swissa, Moshe ^h   Zareba, Wojciech ^b   Moss, Arthur J ^b   Kautzner, Josef ^a   Ruwald, Martin H ^b,c  

^a INSTITUTE FOR CLINICAL AND EXPERIMENTAL MEDICINE   (Czech Republic)

^b UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^c GENTOFTE UNIVERSITY HOSPITAL   (Denmark)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^e AALBORG UNIVERSITY   (Denmark)

^f SEMMELWEIS UNIVERSITY   (Hungary)

^g HOSPITAL INFANTA CRISTINA   (Spain)

^h KAPLAN MEDICAL CENTER   (Israel)

Author keywords

appropriate ICD therapy; implantable cardioverter defibrillators; inappropriate ICD therapy; ischemic cardiomyopathy; MADIT RIT trial; nonischemic cardiomyopathy

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; ANGIOTENSIN RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CONTROLLED STUDY; DEFIBRILLATION; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; INCIDENCE; ISCHEMIC CARDIOMYOPATHY; MAJOR CLINICAL STUDY; MALE; NONISCHEMIC CARDIOMYOPATHY; PREVALENCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; ADVERSE EFFECTS; CARDIOMYOPATHIES; CARDIOVERSION; CHI SQUARE DISTRIBUTION; CLINICAL TRIAL; COMPLICATION; DEATH, SUDDEN, CARDIAC; DEVICE FAILURE; DEVICES; EQUIPMENT DESIGN; EUROPE; HEART FUNCTION TEST; ISRAEL; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTICENTER STUDY; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PATHOPHYSIOLOGY; PREDICTIVE VALUE; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SIGNAL PROCESSING; TACHYCARDIA, VENTRICULAR; TIME; TREATMENT OUTCOME; UNITED STATES;

AGED; CARDIOMYOPATHIES; CHI-SQUARE DISTRIBUTION; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ELECTROPHYSIOLOGIC TECHNIQUES, CARDIAC; EQUIPMENT DESIGN; EQUIPMENT FAILURE; EUROPE; FEMALE; HUMANS; ISRAEL; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; MYOCARDIAL ISCHEMIA; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SIGNAL PROCESSING, COMPUTER-ASSISTED; TACHYCARDIA, VENTRICULAR; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84927691370     PISSN: 10453873     EISSN: 15408167     Source Type: Journal    
DOI: 10.1111/jce.12605     Document Type: Article

References (25)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, Higgins SL, Brown MW, Andrews ML,: Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002; 346: 877-883.
2. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M, Troutman C, Anderson J, Johnson G, McNulty SE, Clapp-Channing N, Davidson-Ray LD, Fraulo ES, Fishbein DP, Luceri RM, Ip JH,: Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med 2005; 352: 225-237.
3. Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, de Marco T, Carson P, DiCarlo L, DeMets D, White BG, DeVries DW, Feldman AM,: Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004; 350: 2140-2150.
4. Daubert JP, Zareba W, Cannom DS, McNitt S, Rosero SZ, Wang P, Schuger C, Steinberg JS, Higgins SL, Wilber DJ, Klein H, Andrews ML, Hall WJ, Moss AJ, Investigators MI: Inappropriate implantable cardioverter-defibrillator shocks in MADIT II: Frequency, mechanisms, predictors, and survival impact. J Am Coll Cardiol 2008; 51: 1357-1365.
5. van Rees JB, Borleffs CJ, de Bie MK, Stijnen T, van Erven L, Bax JJ, Schalij MJ,: Inappropriate implantable cardioverter-defibrillator shocks: Incidence, predictors, and impact on mortality. J Am Coll Cardiol 2011; 57: 556-562.
6. Ruwald MH, Abu-Zeitone A, Jons C, Ruwald AC, McNitt S, Kutyifa V, Zareba W, Moss AJ,: Impact of carvedilol and metoprolol on inappropriate implantable cardioverter-defibrillator therapy: The MADIT-CRT trial (Multicenter Automatic Defibrillator Implantation With Cardiac Resynchronization Therapy). J Am Coll Cardiol 2013; 62: 1343-1350.
7. Wilkoff BL, Ousdigian KT, Sterns LD, Wang ZJ, Wilson RD, Morgan JM, and Investigators ET: A comparison of empiric to physician-tailored programming of implantable cardioverter-defibrillators: Results from the prospective randomized multicenter EMPIRIC trial. J Am Coll Cardiol 2006; 48: 330-339.
8. Wilkoff BL, Williamson BD, Stern RS, Moore SL, Lu F, Lee SW, Birgersdotter-Green UM, Wathen MS, Van Gelder IC, Heubner BM, Brown ML, Holloman KK, and Investigators PS: Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: Results from the PREPARE (Primary Prevention Parameters Evaluation) study. J Am Coll Cardiol 2008; 52: 541-550.
9. Gasparini M, Proclemer A, Klersy C, Kloppe A, Lunati M, Ferrer JB, Hersi A, Gulaj M, Wijfels MC, Santi E, Manotta L, Arenal A,: Effect of long-detection interval vs standard-detection interval for implantable cardioverter-defibrillators on antitachycardia pacing and shock delivery: The ADVANCE III randomized clinical trial. J Am Med Acad 2013; 309: 1903-1911.
10. Moss AJ, Schuger C, Beck CA, Brown MW, Cannom DS, Daubert JP, Estes M 3rd, Greenberg H, Hall WJ, Huang DT, Kautzner J, Klein H, McNitt S, Olshansky B, Shoda M, Wilber D, Zareba W,: Reduction in inappropriate therapy and mortality through ICD programming. N Engl J Med 2012; 367: 2275-2283.
11. Theuns DA, Smith T, Hunink MG, Bardy GH, Jordaens L,: Effectiveness of prophylactic implantation of cardioverter-defibrillators without cardiac resynchronization therapy in patients with ischaemic or non-ischaemic heart disease: A systematic review and meta-analysis. Europace 2010; 12: 1564-1570.
12. Wasmer K, Kobe J, Andresen D, Zahn R, Spitzer SG, Jehle J, Brachmann J, Stellbrink C, Martens E, Hochadel M, Senges J, Klein H, Eckardt L,: Comparing outcome of patients with coronary artery disease and dilated cardiomyopathy in ICD and CRT recipients: Data from the German DEVICE-registry. Clin Res Cardiol 2013; 102: 513-521.
13. Schuger C, Daubert JP, Brown MW, Cannom D, Estes NA 3rd, Hall WJ, Kayser T, Klein H, Olshansky B, Power KA, Wilber D, Zareba W, Moss AJ,: Multicenter automatic defibrillator implantation trial: Reduce inappropriate therapy (MADIT-RIT): Background, rationale, and clinical protocol. Ann Noninvasive Electrocardiol 2012; 17: 176-185.
14. Epstein AE, Dimarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, Gillinov AM, Gregoratos G, Hammill SC, Hayes DL, Hlatky MA, Newby LK, Page RL, Schoenfeld MH, Silka MJ, Stevenson LW, Sweeney MO, American College of Cardiology, American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery and Society of Thoracic Surgeons: ACC/AHA/HRS 2008 Guidelines for device-based therapy of cardiac rhythm abnormalities. Heart Rhythm 2008; 5: e1-62.
15. Cox DR,: Regression models and life-tables. J R Stat Soc Ser B-Stat Meth 1972; 34: 187-220.
16. Cleland JG, Daubert JC, Erdmann E, Freemantle N, Gras D, Kappenberger L, Tavazzi L, and Cardiac Resynchronization-Heart Failure Study Investigators: The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005; 352: 1539-1549.
17. Moss AJ, Hall WJ, Cannom DS, Klein H, Brown MW, Daubert JP, Estes M 3rd, Foster E, Greenberg H, Higgins SL, Pfeffer MA, Solomon SD, Wilber D, Zareba W, for the MADIT-CRT Trial Investigators: Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009; 361: 1329-1338.
18. Strickberger SA, Hummel JD, Bartlett TG, Frumin HI, Schuger CD, Beau SL, Bitar C, Morady F, Investigators A: Amiodarone versus implantable cardioverter-defibrillator: Randomized trial in patients with nonischemic dilated cardiomyopathy and asymptomatic nonsustained ventricular tachycardia-AMIOVIRT. J Am Coll Cardiol 2003; 41: 1707-1712.
19. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, Hoch D, Goldberger J, Shalaby A, Sanders WE, Schaechter A, Levine JH,: Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004; 350: 2151-2158.
20. Bansch D, Antz M, Boczor S, Volkmer M, Tebbenjohanns J, Seidl K, Block M, Gietzen F, Berger J, Kuck KH,: Primary prevention of sudden cardiac death in idiopathic dilated cardiomyopathy: The Cardiomyopathy Trial (CAT). Circulation. 2002; 105: 1453-1458.
21. Smith T, Theuns DA, Caliskan K, Jordaens L,: Long-term follow-up of prophylactic implantable cardioverter-defibrillator-only therapy: Comparison of ischemic and nonischemic heart disease. Clin Cardiol 2011; 34: 761-767.
22. Gandhi K, Aronow WS, Desai H, Amin H, Lai HM, Frishman WH, Cohen M, Sorbera C,: Incidence of appropriate cardioverter-defibrillator shocks and mortality in patients with implantable cardioverter-defibrillators with ischemic cardiomyopathy versus nonischemic cardiomyopathy at 33-month follow-up. Arch Med Sci 2010; 6: 900-903.
23. Wathen MS, DeGroot PJ, Sweeney MO, Stark AJ, Otterness MF, Adkisson WO, Canby RC, Khalighi K, Machado C, Rubenstein DS, Volosin KJ, Pain FRI II,: Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results. Circulation 2004; 110: 2591-2596.
24. Streitner F, Kuschyk J, Dietrich C, Mahl E, Streitner I, Doesch C, Veltmann C, Schimpf R, Wolpert C, Borggrefe M,: Comparison of ventricular tachyarrhythmia characteristics in patients with idiopathic dilated or ischemic cardiomyopathy and defibrillators implanted for primary prevention. Clin Cardiol 2011; 34: 604-609.
25. Ruwald MH, Zareba W, Jons C, Zhang C, Ruwald A-CH, Olshansky B, McNitt S, Thomsen PEB, Shoda M, Merkely B, Moss AJ, Kutyifa V,: Influence of diabetes mellitus on inappropriate and appropriate implantable cardioverter-defibrillator therapy and mortality in the Multicenter Automatic Defibrillator Implantation Trial-Reduce Inappropriate Therapy (MADIT-RIT) Trial. Circulation 2013; 128: 694-701.